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Background and purpose   Joint Replacement Registries play a 
significant role in monitoring arthroplasty outcomes by publish-
ing data on survivorship of individual prostheses or combina-
tions of prostheses. The difference in outcomes can be device- or 
non-device-related, and these factors can be analyzed separately. 
Although registry data indicate that most prostheses have similar 
outcomes, some have a higher than anticipated rate of revision 
when compared to all other prostheses in their class. This report 
outlines how the Australian Orthopaedic Association National 
Joint Replacement Registry (AOANJRR) has developed a method 
to report prostheses with a higher than expected rate of revision. 
These are referred to as “outlier” prostheses.
Material and methods   Since 2004, the AOANJRR has devel-
oped a standardized process for identifying outliers. This is based 
on a 3-stage process consisting of an automated algorithm, an 
extensive analysis of individual prostheses or combinations by 
registry staff, and finally a meeting involving a panel from the 
Australian Orthopaedic Association Arthroplasty Society. Outlier 
prostheses are listed in the Annual Report as (1) identified but no 
longer used in Australia, (2) those that have been re-identified and 
that are still used, and (3) those that are being identified for the 
first time.
Results   78 prostheses or prosthesis combinations have been 
identified as being outliers using this approach (AOANJRR 2011 
Annual Report). In addition, 5 conventional hip prostheses were 
initially identified, but after further analysis no longer met the 
defined criteria. 1 resurfacing hip prosthesis was initially identi-
fied, subsequently removed from the list, and then re-identified 
the following year when further data were available. All unicom-
partmental and primary total knee prostheses identified as having 
a higher than expected rate of revision have continued to be re-
identified.
Interpretation   It is important that registries use a transpar-
ent and accountable process to identify an outlier prosthesis. This 
paper describes the development, implementation, assessment, 
and impact of the approach used by the Australian Registry.

Many factors influence the outcome of joint replacement sur-
gery. Arthroplasty registries are able to identify differences 
in outcome based on patient-, surgery-, or prosthesis-specific 
factors (Herberts 1997, Graves et al. 2004, Hallan et al. 2007, 
Ranstam and Robertsson 2010). The principal measure of 
primary joint replacement surgery is time to first revision, 
generally estimated using the Kaplan-Meier survival method 
(Dobbs 1980). This measure is an unambiguous and clear indi-
cation of a problem with the primary procedure, where both 
the patient and surgeon have agreed that it is serious enough to 
require further surgical intervention (Söderman and Herberts 
2000, Robertsson 2007).
It is known that prostheses have variable outcomes and, 
while most perform well, some have outcomes well out-
side what would be regarded as acceptable. This variability 
in prosthesis performance highlights the need for adequate 
pre-market assessment and vigilant post-market surveillance. 
Joint replacement registries play a critical role in providing 
quality post-market surveillance, as well as helping to under-
stand prosthetic use and improving patient outcomes (Her-
berts 2000, Kolling et al. 2007, Fevang et al. 2010, Graves 
2010). Registries have also been very effective in identifying 
prostheses or combinations of prostheses that are outliers with 
respect to revision rate, when compared to others in the same 
class (Robertsson and Lidgren 2008, Espenhaug et al. 2009, 
de Steiger et al. 2011). 
It is important that registries use a transparent and account-
able process to identify an outlier. The AOANJRR was one of 
the first registries to develop a standardized process for identi-
fication of such prostheses (AOANJRR 2004 Annual Report). 
This process attempts to take into account the extent of differ-
ence and to determine the possible reasons for that difference. 
In this paper we describe the development, implementation, 
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Materials and methods
The AOANJRR began a staged implementation on Septem-
ber 1, 1999 and has collected full national data since 2002. 
This registry has developed a standardized 3-stage approach 
to identifying prostheses that have a higher than expected rate 
of revision. Stage 1 has been present since the Registry com-
menced, stage 2 was introduced in 2003, and stage 3 in 2007.
Stage 1
The first stage is an initial screening test. It is an automated 
analysis that identifies prostheses where the revision rate (per 
100 component years) exceeds twice that of all other prosthe-
ses in the same class, and the Poisson probability of observ-
ing that number of revisions, given the rate of the class, is 
statistically significant (p < 0.05). Additional criteria include 
that there must be at least 10 primary procedures for that pros-
thesis, or the proportion revised is at least 75% and there have 
been at least 2 revisions. In addition, if a particular class con-
tains a prosthesis that represents more than 25% of the group, 
a second probability analysis is performed in stage 1. This 
analysis excludes the prosthesis from the overall rate and the 
probability is re-estimated using only the remaining prosthe-
ses. This is to avoid any bias on the revision rate that may occur 
by including a dominant prosthesis. This initial algorithm 
is based on a well-established epidemiological model iden-
tifying person-time at risk. This represents the observational 
experience in which disease onsets can be observed (Rothman 
1998). Component years are substituted for person-years in 
the Registry model. Individual prostheses are identified but, 
specifically with primary hip replacement, a combination of 
prostheses may be identified. This occurs when a femoral 
stem and acetabular component are implanted together and 
the combination has a higher than expected rate of revision. 
Knee replacements are identified as a specific variant of the 
same brand if only the variant of the brand has a higher rate of 
revision, e.g. Genesis II Oxinium (cementless)/MBK. 
Stage 2
In stage 2, Registry staff—including 3 orthopedic surgeons—
review more detailed information on all prostheses identified 
in stage 1. An important part of stage 2 is the analysis exam-
ining the impact of potential confounders, such as age, pri-
mary diagnosis, and reason for revision, which are known to 
influence implant survival (Ranstam et al. 2011). This process 
seeks to identify patient and surgeon factors as well as device-
related factors that may have contributed to the observed 
higher rate of revision. Prostheses may be excluded from 
further review for a variety of reasons, some of which may 
include inadequate numbers or use in complex primary situa-
tions, or if they have been combined with prostheses already 
known to have a higher rate of revision. Age and sex-adjusted 
hazard ratios are calculated using Cox regression models. If 
the hazard ratio of a particular prosthesis—compared to all 
other prostheses in the same class combined—is statistically 
significant, then the prosthesis or prosthesis combination pro-
gresses to stage 3. Additionally, all prostheses identified in the 
previous Annual Report are included in stage 2, regardless of 
re-identification in stage 1. The reason for this is to ensure 
that these previously identified prostheses undergo a complete 
follow-up assessment. 
Stage 3
In 2007, a third stage of assessment was added, enabling 
senior clinicians from the Australian Orthopaedic Associa-
tion Arthroplasty Society to review the detailed analyses of 
prostheses and combinations identified in stage 2. The panel 
meets with staff from the AOANJRR at a 2-day workshop to 
critically appraise all the information and to determine which 
prostheses should be identified as outliers in the Annual 
Report. At this stage, the expert panel may request Registry 
technical staff to provide further information or additional sta-
tistical analyses.
At the conclusion of stage 3, the AOANJRR then lists iden-
tified prostheses in 1 of 3 groups: (1) those that are no longer 
used in Australia, (2) those that have been re-identified and 
are still used, and (3) those that are being identified for the 
first time. Summary data for each prosthesis or prosthesis 
combination are provided in the Annual Report, and a full 
analysis is available in the supplementary report section on 
the AOANJRR website https://aoanjrr.dmac.adelaide.edu.au/
annual-reports-2012. 
Results 
Between 2004 and 2011, the AOANJRR identified 78 pros-
theses or prosthesis combinations using its 3-stage approach. 
These included 42 conventional and 6 resurfacing hip prosthe-
ses and also 5 unicompartmental and 25 total knee prostheses. 
In general, once a prosthesis or prosthesis combination has 
been identified, it continues to be identified as an outlier in 
subsequent years. There have been 5 primary conventional hip 
prostheses or combinations that have been used in more than 
150 procedures that were initially identified and subsequently 
after 1 year no longer satisfied the defined criteria. 1 resur-
facing hip prosthesis was initially identified, subsequently 
removed from the list, and then re-identified the following 
year when further data were available. All unicompartmen-
tal and primary total knee prostheses previously identified as 
having a higher than epected rate of revision have been re-
identified (AOANJRR 2011 Annual Report). 
During preparation of the 2011 Annual Report, the AOAN-
JRR identified 217 prostheses or prosthesis combinations in 
stage 1. Of these, 123 (56.6%) were analyzed in more detail in 
stage 2. Those that did not show a statistically significant dif-
ference in the rate of revision compared to the combination of 
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3, there were 95 (44%) prostheses or prosthesis combinations 
reviewed by the independent panel of orthopedic surgeons and 
17 were excluded. Reasons for exclusion included identify-
ing non-prostheses-related factors such as major differences in 
primary diagnosis, or where surgeon specific factors were felt 
to be contributing to the higher than expected revision rate.
Overall, there were 78 prostheses (36%) or prosthesis 
combinations identified in 2011, and 17 of these were newly 
identified (Table). These prostheses comprise 3.5% of all the 
different primary hip and knee replacements that have been 
recorded by the Registry. Of the prostheses identified, 37 of 
78 (47%) are no longer used on the Australian market, and of 
those prostheses that were re-identified and were still used, 18 
of 24 (75%) had had reduced use compared to the previous 
year. 14 combinations of acetabular cup and femoral stems 
have been reported that do not feature as individual prosthe-
ses, but when combined they have a higher than expected rate 
of revision. 
Discussion
The approach to identifying “outlier” prostheses varies 
between arthroplasty registries. The Swedish Hip Arthroplasty 
Register publishes survivorship curves of prostheses and com-
binations but makes no specific comparison (Swedish Hip 
Arthroplasty Register - Annual Report 2010). The Norwegian 
Register documents the use of prostheses and publishes out-
comes in peer-reviewed journals, but does not report specific 
survivorship curves in its annual report (Norwegian Arthro-
plasty Registry - Annual Report 2010). The New Zealand 
Joint Registry (New Zealand Registry - Annual Report 2011) 
publishes tables of prosthesis outcomes but does not identify 
outlying prostheses. The National Joint Registry for England 
and Wales has developed an outlier subcommittee to discuss 
strategy and methodology for analysis of data on each implant 
that has been highlighted as needing evaluation, but these have 
not been published as yet (National Joint Registry - Annual 
Report 2011).
The Swedish Knee Arthroplasty Register uses a different 
approach. A specific knee prosthesis is used as a reference 
to compare the outcome of other prostheses (Swedish Knee 
Arthroplasty Register Annual Report 2010). The choice of an 
index prosthesis requires that the prosthesis is used in num-
bers large enough to allow adequate comparison. At one point, 
the AOANJRR compared all unicompartmental knees to the 
most frequently implanted prosthesis, the Oxford 3. This was 
because at that time it was used in a large proportion (35%) 
of all unicompartmental prostheses (AOANJRR 2006 Annual 
Report). Since then, the proportion has diminished each year 
and it became no longer appropriate to use an approach for 
unicompartmental knee replacement that was different to that 
being used for all other classes of prostheses.
The AOANJRR chose to identify outlying prostheses within 
2 years of collecting full national data, and this paper describes 
the development and evolution of the method over time. It is 
a transparent and accountable process that culminates in an 
independent review to determine what devices should be iden-
tified as outlier prostheses. It is important for surgeons to have 
current information on prosthesis outcomes, to enable them to 
select the best-performing devices for their patients. Registries 
provide an ideal form of post-market surveillance that is read-
ily able to achieve this. Other surveillance measures such as 
adverse event reporting are known to have limitations (Hauser 
2012, Heard et al. 2012, Willis et al. 2012, ). Most impor-
tantly, these are very dependent on what is reported and there 
is no provision of information on comparative performance. It 
is also necessary for regulatory authorities and industry to be 
aware of outlier prostheses as, even with internal monitoring, 
the real number of revisions may not be apparent (de Stei-
ger et al. 2011, Zuckerman et al. 2011, McGee et al. 2012). 
Following a health technology assessment review, and in part 
based on registry data, the Australian government reclassified 
hip, knee, and shoulder replacements from Class IIB to Class 
III (high-risk medical devices) (Therapeutic Goods Adminis-
tration Regulation Impact Statement 2012). Since 2007, the 
Registry approach to identification has also been incorporated 
into the regulatory processes in this country. Following the 
release of the AOANJRR Annual Report, the Therapeutic 
Goods Administration (TGA), which is the Australian regula-
tory affairs body for medicines and devices, requests further 
information from the industry to justify the continued use of 
products identified as having a higher than expected rate of 
revision. The response of the industry to the Registry data is 
Identification of outlier prostheses by stage
Prosthesis type Identified in  Analyzed in  Reviewed in Identified Newly identified
 stage 1  stage 2 stage 3 overall in 2011
Hips
 Total conventional 150 83 56 42 13
 Total resurfacing 7 6 6 5 1
Knees
 Unicompartmental  5 6 6 6 1
 Total knee 55 28 27 25 2
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then reviewed by another specialist orthopedic TGA commit-
tee, which makes recommendations about the ongoing use of 
the individual prostheses (TGA Reforms 2011).
The Registry analyses the rate of revision separately for 
acetabular and femoral components, and if there is a higher 
than anticipated rate, individual components are published in 
the Annual Report. The Registry also analyses all combina-
tions of acetabular and femoral components. Occasionally, a 
combination of prostheses—only when used together—has a 
higher than anticipated rate of revision, and this combination 
is noted. 
A well-performing prosthesis can also be linked to a pros-
thesis known to have a higher than expected revision rate, so 
that the combination performs less satisfactorily. The Corail/
ASR combination was first reported in 2008 as having a revi-
sion rate that was more than twice its comparators even though 
good results had already been reported for the Corail stem 
(AOANJRR 2008 Annual Report). This was the first time that 
the ASR acetabular component, which had previously been 
reported with resurfacing (AOANJRR 2007 Annual Report), 
was associated with an increased rate of revision in conven-
tional hip replacement. In other cases, an individual compo-
nent is associated with a higher than expected revision rate no 
matter what prosthesis it is implanted with. If a prosthesis or 
combination previously identified no longer meets the criteria, 
it is not re-identified subsequently and this is documented in 
the Annual Report. Registries continually monitor changing 
outcomes, and it is important to note that the report reflects 
that particular time period. 
There are both strengths and limitations to the process by 
which the AOANJRR identifies prostheses with higher than 
anticipated rates of revision. Stage 1 is effective as a screen-
ing test to flag prostheses but it does not account for changes 
in revision rate over time. This limitation makes it difficult to 
detect a difference if the higher risk of revision occurs later 
in the follow-up period (Hardoon et al. 2006). The introduc-
tion of stage 2 enabled further analysis to be performed on 
a number of variables, both device- and non-device-related. 
Stage 3 has proven to be valuable because it broadens the 
clinical perspective available to the AOANJRR. With the large 
number of prostheses reported to the Registry, it is difficult for 
the Registry surgeons to have a working knowledge of all the 
devices. The addition of members of the Arthroplasty Society 
broadens the clinical perspective. Surgeons involved in stage 3 
have experience of many of the devices and add valuable input 
to the Registry findings. This improves the transparency and 
accountability of the Annual Report by ensuring peer review 
by the peak arthroplasty body in the country. 
The Registry compares prostheses to all remaining com-
ponents in their class, and therefore under-reports prostheses 
with a higher than expected revision rate compared to the situ-
ation where the Registry only used the better-performing pros-
theses as the comparator. When a prosthesis with a higher than 
expeec ted revision rate has been identified, it usually contin-
ues to be identified in subsequent reports. . After identification 
of the device, the usage usually declines—which may have a 
significant effect on its subsequent outcome, for a variety of 
reasons. Identification may bring the prosthesis to the attention 
of surgeons not performing large enough numbers to be aware 
that it has a higher rate of revision. They may then change 
their choice of prosthesis. It may also highlight patient selec-
tion issues such as resurfacing hip arthroplasty having a higher 
rate of revision in women, patients with smaller-diameter fem-
oral heads, and older patients (Prosser et al. 2010). This may 
result in a change of indication for prosthesis use, which has 
been shown in the Registry (AOANJRR 2011 Annual Report)
The Registry is most effective at identifying the performance 
of recently introduced prostheses, but those prostheses with 
delayed onset of a higher rate of revision are not identified as 
readily. It has become evident that the approach to identifica-
tion may be too broad, and it is important to perform a careful 
range analysis of prostheses to identify which particular type is 
responsible for the higher than expected rate of revision within 
that particular group. An early example of this process was the 
Preservation Unicompartmental Knee, which was first iden-
tified in 2004 (AOANJRR 2004 Annual Report). In 2006, it 
became apparent that only the mobile bearing component had 
an increased rate of revision (AOANJRR 2006 Annual Report). 
More recent examples of prostheses that were not identified 
on routine screening but that required specific sub-analysis 
include the LCS/Duofix knee and size issues associated with 
the Spectron femoral stem. The Registry will continue to 
develop further strategies to identify specific prostheses within 
a broader group, keeping in mind that reducing the numbers 
available for analysis may reduce statistical precision.
The Registry is aware that a single surgeon may be responsi-
ble for a prosthesis combination that has a higher rate of revi-
sion. This situation has occurred twice, and on both occasions 
subsequent use of the combination ceased following publica-
tion of the Annual Report.
Identification by registries of prostheses with a higher than 
expected rate of revision is a process that will continue to 
evolve and develop. This will be enhanced by international col-
laboration between registries, which includes the possibility of 
using other registries to verify or confirm outlier prostheses. In 
addition, systems could be established to enable data pooling, 
which would allow enhanced analysis to better understand the 
role of device-related and non-device-related factors that may 
contribute to the higher revision rate identified. 
Conclusion
Many approaches for systematic reduction of the rate of revi-
sion have been described. Identification of prostheses with 
a higher than expected rate of revision is far less widely 
reported. Arthroplasty registries are effective in identifying 
outliers, and they can determine multiple factors that affect 
outcome—including device- and non-device-related issues. 
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and, as a result, many outlier prostheses are no longer on the 
market. Registries and international collaboration between 
registries will continue to play a major role.
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